Immune Checkpoint Inhibitor–Induced Pancreatic Injury: An Emerging Form of Immune-Mediated Pancreatitis

ICI-PI is an uncommon yet clinically important entity that shows a distinct clinicopathologic profile from other forms of AIP. Clear diagnostic criteria, practical treatment pathways, and prospective registries are needed to guide therapy, inform rechallenge decisions, and define long-term outcomes.

Authors

Institutions

Publication Details

Journal
Pancreas
Published
2025-10-13
DOI
https://doi.org/10.1097/mpa.0000000000002582
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immune Checkpoint Inhibitor–Induced Pancreatic Injury: An Emerging Form of Immune-Mediated Pancreatitis

Tareq Alsaleh, John C. George
Pancreas
Neuroendocrine Tumor Research Advances
article

Immune Checkpoint Inhibitor–Induced Pancreatic Injury: An Emerging Form of Immune-Mediated Pancreatitis

Tareq Alsaleh, John C. George
article en

Abstract

ICI-PI is an uncommon yet clinically important entity that shows a distinct clinicopathologic profile from other forms of AIP. Clear diagnostic criteria, practical treatment pathways, and prospective registries are needed to guide therapy, inform rechallenge decisions, and define long-term outcomes.

PancreasVol. 55(4)
AdventHealth Orlando (US), AdventHealth East Orlando (US)
Openalex Percentile: Top 61%
Neuroendocrine Tumor Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.